This second edition of “Biomarker Days”, devoted to Infectiology and co-organized with the Regional Economic Development Agency AD’OCC and the Eurobiomed competitiveness cluster, was a popular success with more than 250 participants (more than the first edition), including researchers and technical personnel, physicians, industry representatives, students, and institutional representatives.

Internationally recognized speakers presented the latest advances and perspectives in various domains, such bacteriology, virology, and sepsis (see the meeting program).

One of the meeting’s highlights on June 15 was the launch of the MUSE Key Initiative – KIM “Biomarkers & Therapy” – by Françoise Bons (Regional Councilor), Philippe Augé (President, University of Montpellier), Christian Le Ludec (General Manager of the Montpellier University Hospital Center), François Pierrot (Executive Director of MUSE I-Site), Prof. Philippe Berta (Board member of the Eurobiomed Competitiveness Cluster & President of the Orphan Disease Group of the French National Assembly), and Prof. Sylvain Lehmann (KIM Leader & Scientific director).

The meeting concluded with a pitch-poster session where participants could present their work and interact or plant the seeds for future collaborations with relevant people.